Related Experiment Video
Updated: Jun 1, 2026

Evaluating In Vitro DNA Damage Using Comet Assay
Published on: October 11, 2017
Another cause of pancytopenia in a patient receiving temozolomide
Yavuz Pehlivan1, Alper Sevinc, Ibrahim Halil Turkbeyler
1Department of Internal Medicine, School of Medicine, Gaziantep University, Sahinbey Medical Center, Gaziantep, Turkey. drpehlivan@hotmail.com
Objective:
To report pancytopenia caused by temozolomide, a second-generation alkylating agent.
Clinical Presentation And Intervention:
A 22-year-old patient presenting with seizures and confusion was seen in the emergency room. Cranial magnetic resonance imaging revealed a mass. After surgery, the patient was diagnosed with glioblastoma multiforme and was given temozolomide at 150 mg/m(2) on days 1 through 5 every 4 weeks. During the last cycle of temozolomide, grade 3 thrombocytopenia persisted. Possible causes of pancytopenia including vitamin B(12) deficiency were investigated.
Conclusion:
This case report shows that vitamin B(12) deficiency can be a potential cause of pancytopenia and it should be kept in mind for patients receiving chemotherapy.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Treatment Resistant Cancers
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Abnormal Proliferation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

